From: Identification of significant modules and hub genes involved in hepatic encephalopathy using WGCNA
Term | p-value | q-value | overlap_genes |
---|---|---|---|
Tamibarotene CTD 00002527 | 0.000013 | 0.003889 | [HLA-DMB, ALOX5AP, CYBB, CYBA, LGALS9, AIF1] |
leukotriene C4 CTD 00007223 | 0.000128 | 0.019335 | [SYK, ALOX5AP] |
dioxidanide CTD 00006819 | 0.000620 | 0.062370 | [CYBB, CYBA] |
valproic acid HL60 DOWN | 0.000921 | 0.066995 | [SYK, PTPN6, LAIR1] |
Sodium dichromate CTD 00000827 | 0.001109 | 0.066995 | [SLC7A7, AIF1, LAIR1] |
TACROLIMUS MONOHYDRATE CTD 00007118 | 0.001519 | 0.076433 | [CYBA, CCR3] |
NADP( +) BOSS | 0.003302 | 0.132900 | [CYBB, CYBA] |
pergolide HL60 UP | 0.003521 | 0.132900 | [RBM47, FCGR2A, CYBB] |
mebendazole HL60 UP | 0.004703 | 0.157814 | [RBM47, FCGR2A, SLC7A7] |
Medroxyprogesterone acetate CTD 00006623 | 0.006509 | 0.166665 | [C1QA, ALOX5AP, AIF1] |